# Lavender Essential Oil-Induced Enhancement of Exercise-Responsive Myokine Expression and Alteration of Muscle-Related Gene Networks in an in Vitro Muscle Contraction Model

**Authors:** Fumiko Takenoya, Junko Shibato, Michio Yamashita, Makoto Kanzaki, Yasuhiro Yamazaki, Yoshihiko Chiba, Takahiro Hirabayashi, Seiji Shioda, Randeep Rakwal

PMC · DOI: 10.3390/ijms27041952 · International Journal of Molecular Sciences · 2026-02-18

## TL;DR

This study explores how lavender essential oil affects muscle cells during simulated exercise, finding that it boosts a recovery-related protein and changes gene activity.

## Contribution

The study provides the first molecular evidence that lavender essential oil modulates muscle gene networks in a contraction-dependent manner.

## Key findings

- Lavender essential oil increased IL-6 mRNA expression in muscle cells under electrical pulse stimulation.
- DNA microarray analysis revealed LEO-induced changes in gene expression profiles depending on muscle contraction state.
- Linalool permeated human epidermis, while linalyl acetate showed minimal permeation, with saturation observed above 5% concentration.

## Abstract

Lavender essential oil (LEO) is commonly used in aromatherapy for stress reduction, relaxation and recovery from (muscle) fatigue. However, molecular mechanisms underlying its potential physiological effects on the skeletal muscle remain unclear. This study investigates whether LEO affects the intracellular signaling pathways in skeletal muscle cells that respond to physical activity. Prior to the experiment, GC-MS analysis confirmed linalyl acetate and linalool as the main components of LEO used in this study. Transdermal permeability was assessed using a reconstructed human epidermis model, which showed that linalool permeated the epidermal layer, while linalyl acetate showed minimal permeation. Following this confirmation, the differentiated C2C12 myotubes were treated with LEO in an in vitro muscle contraction model using electrical pulse stimulation (EPS). LEO significantly increased Interleukin 6 (IL-6) mRNA expression under EPS, and DNA whole-genome microarray analysis showed that LEO induced different gene expression profiles depending on the contraction state of the muscle cells. These results provide the first molecular evidence that LEO modulates skeletal muscle gene networks in a stimulation-dependent manner and may indicate its potential use as an aid to recovery (from fatigue) after exercise. Notably, the skin permeation of LEO components showed a saturation trend at concentrations above 5%, suggesting the presence of an optimal concentration range for topical application in sports aromatherapy.

## Linked entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569]
- **Chemicals:** linalyl acetate (PubChem CID 8294), linalool (PubChem CID 6549)

## Full-text entities

- **Genes:** Nr4a1 (nuclear receptor subfamily 4, group A, member 1) [NCBI Gene 15370] {aka GFRP1, Gfrp, Hbr-1, Hbr1, Hmr, N10}, Angptl4 (angiopoietin-like 4) [NCBI Gene 57875] {aka Arp4, Bk89, Fiaf, Hfarp, Ng27, Pgar}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Myo1d (myosin ID) [NCBI Gene 338367] {aka 9930104H07Rik, D11Ertd9e, myosin-1d}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Tnfrsf1a (tumor necrosis factor receptor superfamily, member 1a) [NCBI Gene 21937] {aka CD120a, FPF, TNF-R, TNF-R-I, TNF-R1, TNF-R55}, Myod1 (myogenic differentiation 1) [NCBI Gene 17927] {aka MYF3, MyoD, Myod-1, bHLHc1}, Hey1 (hairy/enhancer-of-split related with YRPW motif 1) [NCBI Gene 15213] {aka CHF2, HRT1, Herp2, Hesr1, bHLHb31, hesr-1}, Myog (myogenin) [NCBI Gene 17928] {aka MYF4, bHLHc3, myo}
- **Diseases:** injury to (MESH:D014947), inflammation (MESH:D007249), Muscle (MESH:D019042), anxiety (MESH:D001007), Toxicity (MESH:D064420), muscle soreness (MESH:D063806), fatigue (MESH:D005221), muscle injury (MESH:D009135), EPS (MESH:D004556)
- **Chemicals:** 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MESH:C022616), Dulbecco's Modified Eagle's Medium (-), camphor (MESH:D002164), penicillin (MESH:D010406), Linalool (MESH:C018584), Linalyl Acetate (MESH:C074463), MTT (MESH:C070243), Jojoba oil (MESH:C034743), ethidium bromide (MESH:D004996), streptomycin (MESH:D013307), carbon (MESH:D002244), Oil (MESH:D009821), monoterpene (MESH:D039821), LEO (MESH:C045718), CO2 (MESH:D002245), Essential Oil (MESH:D009822), agarose (MESH:D012685), terpenes (MESH:D013729), lipid (MESH:D008055), Cy (MESH:D003545), HCl (MESH:D006851), hydrogen (MESH:D006859), Cy5 (MESH:C085321), formaldehyde (MESH:D005557), glucose (MESH:D005947), DMSO (MESH:D004121)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G2505C
- **Cell lines:** C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940430/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940430/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940430/full.md

---
Source: https://tomesphere.com/paper/PMC12940430